Raise by Fusion42
Fusion42 Scout Wire
Capital Reports
Who's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC
Benchmarks
Benchmarks HomeFundsRoundsSectors
AI VC IndexCapital FlowAbout

Switch product

Fusion42RaiseScoutWire

Capital Reports

All editionsWho's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC

Database & benchmarks

Benchmarks HomeFundsRoundsSectorsStagesAI VC IndexCapital Flow Index

Account

Sign in
← Back

Osage University Partners | Penn-BioNTech Innovative Therapeutics Seed Fund

vc$50M

◆ Fund Size

$50M

◆ Location

United States

◆ Share this fund

ShareXLinkedInEmail

◆ About Osage University Partners

A $50 million venture capital fund established by the University of Pennsylvania, BioNTech, and Osage University Partners to support early-stage life sciences companies based on university intellectual property and research. The fund invests in companies commercializing biomedical discoveries from academic institutions.

◆ Sectors

BiotechDrug Discovery

◆ Stages

seed

◆ Geography Focus

United States

◆ FAQ

What does Penn-BioNTech Innovative Therapeutics Seed Fund invest in?

Penn-BioNTech Innovative Therapeutics Seed Fund invests in Biotech and Drug Discovery at the seed stage.

Which geographies does Penn-BioNTech Innovative Therapeutics Seed Fund focus on?

Penn-BioNTech Innovative Therapeutics Seed Fund focuses on United States, and is headquartered in United States.